CR

PR

SD

PD

总计

ORR

DCR

PFS/月

Gefitinib

0

7

9

10

26

26.9%

61.5%

9.5

Erlotinib

0

9

10

7

26

34.6%

73.0%

10

Icotinib

0

11

8

5

24

45.8%

79.2%

9.5